Francis C Cordova1, David Ciccolella1, Carla Grabianowski1, John Gaughan2, Kathleen Brennan1, Frederick Goldstein3, Michael R Jacobs1,4, Gerard J Criner1. 1. 1 Department of Thoracic Medicine and Surgery, Temple University School of Medicine , Philadelphia, Pennsylvania. 2. 2 Biostatistics Consulting Center, Temple University School of Medicine , Philadelphia, Pennsylvania. 3. 3 Department of Neuroscience, Physiology, and Pharmacology, Philadelphia College of Osteopathic Medicine , Philadelphia, Pennsylvania. 4. 4 Temple University School of Pharmacy , Philadelphia, Pennsylvania.
Abstract
BACKGROUND:Patients with chronic obstructive pulmonary disease (COPD) may not recognize worsening symptoms that require intensification of therapy. They may also be reluctant to contact a healthcare provider for minor worsening of symptoms. A telemedicine application for daily symptom reporting may reduce these barriers and improve patient outcomes. MATERIALS AND METHODS:Patients hospitalized for a COPD exacerbation within the past year or using supplemental O2 were approached for participation. Patients received optimal COPD care and were given a telecommunication device for symptom reporting. Initial symptom scores were obtained while patients were in their usual state of health. Patients were randomly assigned to an intervention group or a control group (usual medical care). The control group patients were instructed to seek medical care if their condition worsened. The intervention group symptom scores were assessed by a computer algorithm and compared with initial values. Scores 1 or more points above the initial score generated an "alert," and patients were reviewed by a nurse and referred to a physician who prescribed treatment. RESULTS:Eighty-six patients were screened; 79 met entry criteria and were randomized (intervention group, n=39; control group, n=40). Twelve patients submitted five or fewer symptom reports (5 intervention; 7 control) and were excluded from the analysis. Daily peak flow and dyspnea scores improved only in the intervention group. There were no differences in hospitalization and mortality rates between groups. No serious adverse events were reported. CONCLUSIONS: A telemedicine-based symptom reporting program facilitated early treatment of symptoms and improved lung function and functional status.
RCT Entities:
BACKGROUND:Patients with chronic obstructive pulmonary disease (COPD) may not recognize worsening symptoms that require intensification of therapy. They may also be reluctant to contact a healthcare provider for minor worsening of symptoms. A telemedicine application for daily symptom reporting may reduce these barriers and improve patient outcomes. MATERIALS AND METHODS:Patients hospitalized for a COPD exacerbation within the past year or using supplemental O2 were approached for participation. Patients received optimal COPD care and were given a telecommunication device for symptom reporting. Initial symptom scores were obtained while patients were in their usual state of health. Patients were randomly assigned to an intervention group or a control group (usual medical care). The control group patients were instructed to seek medical care if their condition worsened. The intervention group symptom scores were assessed by a computer algorithm and compared with initial values. Scores 1 or more points above the initial score generated an "alert," and patients were reviewed by a nurse and referred to a physician who prescribed treatment. RESULTS: Eighty-six patients were screened; 79 met entry criteria and were randomized (intervention group, n=39; control group, n=40). Twelve patients submitted five or fewer symptom reports (5 intervention; 7 control) and were excluded from the analysis. Daily peak flow and dyspnea scores improved only in the intervention group. There were no differences in hospitalization and mortality rates between groups. No serious adverse events were reported. CONCLUSIONS: A telemedicine-based symptom reporting program facilitated early treatment of symptoms and improved lung function and functional status.
Authors: Andrew J Farmer; Oliver J Gibson; Christina Dudley; Kathryn Bryden; Paul M Hayton; Lionel Tarassenko; Andrew Neil Journal: Diabetes Care Date: 2005-11 Impact factor: 19.112
Authors: Alexander G Logan; Warren J McIsaac; Andras Tisler; M Jane Irvine; Allison Saunders; Andrea Dunai; Carlos A Rizo; Denice S Feig; Melinda Hamill; Mathieu Trudel; Joseph A Cafazzo Journal: Am J Hypertens Date: 2007-09 Impact factor: 2.689
Authors: Rick Carter; David B Holiday; Carol Grothues; Chiagozie Nwasuruba; James Stocks; Brian Tiep Journal: J Cardiopulm Rehabil Date: 2002 Jul-Aug Impact factor: 2.081
Authors: Vincent S Fan; J Michael Gaziano; Robert Lew; Jean Bourbeau; Sandra G Adams; Sarah Leatherman; Soe Soe Thwin; Grant D Huang; Richard Robbins; Peruvemba S Sriram; Amir Sharafkhaneh; M Jeffery Mador; George Sarosi; Ralph J Panos; Padmashri Rastogi; Todd H Wagner; Steven A Mazzuca; Colleen Shannon; Cindy Colling; Matthew H Liang; James K Stoller; Louis Fiore; Dennis E Niewoehner Journal: Ann Intern Med Date: 2012-05-15 Impact factor: 25.391
Authors: Heidi S Smith; Andrew J Criner; Dolores Fehrle; Carla L Grabianowski; Michael R Jacobs; Gerard J Criner Journal: Telemed J E Health Date: 2015-10-09 Impact factor: 3.536
Authors: Jennifer L Rosenthal; Ilana S Sigal; Rory Kamerman-Kretzmer; Daphne S Say; Bianca Castellanos; Stephanie Nguyen; Natasha A Nakra; Bibiana Restrepo; Stephanie S Crossen Journal: Pediatr Qual Saf Date: 2021-06-23